MedTrace Logo

Post Market Registry for GORE® TAG® Thoracic Branch Endoprosthesis

NCT06507865 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2025-05-09

No results posted yet for this study

Summary

The goal of this observational study is to collect mid-term post-market clinical follow-up data of GORE® TAG® Thoracic Branch Endoprosthesis used according to the standard medical practice in patients presenting with vascular disease. This registry aims to answer questions related to the efficacy and safety of GORE® TAG® Thoracic Branch Endoprosthesis.

Conditions

  • Aneurysm
  • Dissection, Aortic
  • TAA Thoracoabdominal Aortic Aneurysm
  • Thoracic Aortic Aneurysm
  • Transection Aorta

Interventions

DEVICE

GORE® TAG® Thoracic Branch Endoprosthesis

Patients presenting with thoracic vascular disease that may benefit from the placement of TBE device. The target registry population is patients who are treated with TBE at participating sites. TBE treatment is qualified as receiving the TBE aortic component, at a minimum.

Sponsors & Collaborators

  • W.L.Gore & Associates

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-20
Primary Completion
2031-04-30
Completion
2031-04-30
FDA Device
Yes

Countries

  • Austria
  • Denmark
  • Germany
  • Greece
  • Italy
  • Netherlands
  • Spain
  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06507865 on ClinicalTrials.gov